Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EEF2K | O00418 | 1/20 | 0.37 |
| ▸ | GBA1 | P04062 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CCR5 | P51681 | 5/20 | 0.34 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 3/20 | 0.32 |
| ▸ | CES1 | P23141 | 3/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21049582 | 1.00 | EEF2K (0.37) | EEF2KGBA1ALDH1A1CCR5SOAT1 | |
| SCHEMBL21049651 | 1.00 | EEF2K (0.37) | EEF2KGBA1ALDH1A1CCR5SOAT1 | |
| SCHEMBL22188985 | 1.00 | EEF2K (0.37) | EEF2KGBA1ALDH1A1CCR5SOAT1 | |
| SCHEMBL21049532 | 1.00 | EEF2K (0.37) | EEF2KGBA1ALDH1A1CCR5SOAT1 | |
| SCHEMBL21049643 | 0.94 | MEN1 (0.33) | EEF2K | |
| SCHEMBL21049559 | 0.84 | INMT (0.33) | — | |
| SCHEMBL22188978 | 0.82 | EEF2K (0.41) | EEF2KGBA1ALDH1A1CCR5SOAT1 | |
| SCHEMBL21049636 | 0.78 | CYP2D6 (0.34) | — | |
| SCHEMBL21049555 | 0.77 | HSD11B1 (0.32) | — | |
| SCHEMBL21049638 | 0.77 | KDM4E (0.33) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3604287-B1 | PRODUCTION METHOD FOR AMIDATE COMPOUND | KOEI CHEMICAL CO (JP) | 2022-08-03 | — | — | EP | disclosed |
| EP-3495353-B1 | AMIDATE COMPOUND, CATALYST FOR POLYURETHANE PRODUCTION, AND METHOD FOR PRODUCING POLYURETHANE RESIN | KOEI CHEMICAL CO (JP) | 2021-11-17 | — | — | EP | disclosed |
| US-10913724-B2 | Production method for amidate compound | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2021-02-09 | — | — | US | disclosed |
| US-10689478-B2 | Amidate compound, catalyst for polyurethane production, and method for producing polyurethane resin | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2020-06-23 | — | — | US | disclosed |
| EP-3604287-A1 | PRODUCTION METHOD FOR AMIDATE COMPOUND | Koei Chemical Company, Limited (JP) | 2020-02-05 | — | — | EP | disclosed |
| US-20190177464-A1 | AMIDATE COMPOUND, CATALYST FOR POLYURETHANE PRODUCTION, AND METHOD FOR PRODUCING POLYURETHANE RESIN | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2019-06-13 | — | — | US | disclosed |
| EP-3495353-A1 | AMIDATE COMPOUND, CATALYST FOR POLYURETHANE PRODUCTION, AND METHOD FOR PRODUCING POLYURETHANE RESIN | Koei Chemical Company, Limited (JP) | 2019-06-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10913724-B2 | Production method for amidate compound | NAAA, PAM, CCKBR | EEF2K 2879/4885GBA1 1860/4885ALDH1A1 1542/4885 |
| US-10689478-B2 | Amidate compound, catalyst for polyurethane production, and method for producing polyurethane resin | ARG1, NIT2, RER1 | EEF2K 3836/4885GBA1 4065/4885ALDH1A1 1488/4885 |
| US-20190177464-A1 | AMIDATE COMPOUND, CATALYST FOR POLYURETHANE PRODUCTION, AND METHOD FOR PRODUCING POLYURETHANE RESIN | ARG1, NIT2, RER1 | EEF2K 3836/4885GBA1 4065/4885ALDH1A1 1488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.